TriangleNCT00382070 · OUTCOME
Distant Recurrence
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of patients
- Interval / dispersion
- Not reported
- Time frame
- 7 years
What was measured
Cumulative incidence of distant recurrences.
Groups in this outcome
Group 2 Letrozole
Patients receive oral letrozole once daily for up to 5 years. Letrozole: Letrozole 2.5 mg taken orally once daily for 5 years
Group 1 Placebo
Patients receive oral placebo once daily for up to 5 years. Placebo: Placebo tablet taken orally once daily for 5 years
| Group | Source count |
|---|---|
| Group 2 Letrozole | 1950 |
| Group 1 Placebo | 1953 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Group 2 Letrozole | 3.9 | Not reported | Not reported | Not reported | Not reported |
| Group 1 Placebo | 5.8 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 3.9
- group Id
- OG001
- value
- 5.8
- denoms
- counts
- group Id
- OG000
- value
- 1950
- group Id
- OG001
- value
- 1953
- units
- Participants
- description
- Cumulative incidence of distant recurrences.
- groups
- description
- Patients receive oral letrozole once daily for up to 5 years. Letrozole: Letrozole 2.5 mg taken orally once daily for 5 years
- id
- OG000
- title
- Group 2 Letrozole
- description
- Patients receive oral placebo once daily for up to 5 years. Placebo: Placebo tablet taken orally once daily for 5 years
- id
- OG001
- title
- Group 1 Placebo
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 7 years
- title
- Distant Recurrence
- type
- SECONDARY
- unit Of Measure
- percentage of patients
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice